AzTrials
AzTrials

Healthy Young WomenIMA-SH & ExercNCT07181044

Exercise, IMA and Sulfhydryl Biomarkers in Young Women

An observational study of Healthy Young Women and Regular Exercise, run by Duvenciler Anadolu Lİsesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent… Read more about this study

Who is it for?
Ages 18 to 25 years, women onlyHealthy volunteers can take part
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Jan 2022to 20 Mar 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Thirty healthy women aged 18-25 years were recruited. Fifteen had a history of regular structured exercise training, while fifteen had sedentary lifestyles without structured exercise.

Who may be able to join

  • Healthy women aged 18-25 years
  • For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
  • For control group: No structured exercise background, only daily living activity

Who cannot join

  • History of chronic cardiovascular, metabolic, or endocrine disorders
  • Smoking or alcohol abuse
  • Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
  • Irregular or intermittent exercise participation not meeting the defined threshold

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yüzüncü Yıl University, Central Research Laboratory

    Van, Muş, 49100

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women

Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent antioxidant capacity, respectively. However, data on their interplay in young women engaged in structured exercise remain scarce.

Objective: This study aimed to investigate the effects of regular exercise on serum IMA and -SH concentrations in healthy young women, thereby providing insights into exercise-induced redox remodeling and sex-specific physiological adaptations.

Methods: A cross-sectional design was employed involving 30 healthy women aged 18-25 years. Participants were divided into an exercise group (n = 15), who had performed structured training ≥3 sessions per week for at least one year, and a control group (n = 15) with no structured exercise history. Venous blood samples were collected after overnight fasting. Serum IMA was quantified using the albumin-cobalt binding assay, and -SH concentrations were determined via the Ellman method. All analyses were performed in duplicate under standardized laboratory conditions. Independent samples t-tests were applied, and effect sizes (Cohen's d) were calculated with 95% confidence intervals.

Read the detailed description

Regular physical activity is widely recognized as a key determinant of human health, conferring benefits across cardiovascular, metabolic, endocrine, and immune systems. Beyond traditional outcomes, habitual exercise plays a pivotal role in regulating oxidative stress and maintaining redox homeostasis. However, few studies have concurrently investigated ischemia-modified albumin (IMA), a marker of oxidative protein modification, and total sulfhydryl groups (-SH), a marker of thiol-dependent antioxidant defense, particularly in young women. The present study was therefore designed to provide novel insights into exercise-induced redox adaptations in this underrepresented population.

This investigation employed an observational, cross-sectional design conducted in accordance with the STROBE guidelines for reporting observational research. Ethical approval was granted by the Muş Alparslan University Scientific Research Ethics Committee (Approval No: 27750; 01 November 2021), and all procedures complied with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to data collection.

A total of 30 healthy women aged 18-25 years were recruited. Participants were categorized into two groups:

Exercise group (n = 15): Women who had been consistently engaged in structured training for at least 12 months, with a minimum frequency of three sessions per week. Training programs were multimodal and typically included aerobic exercise (e.g., running, cycling, swimming at 60-75% HRmax for 20-30 minutes), resistance training (3 sets of 8-12 repetitions at moderate-to-high intensity, targeting major muscle groups), and flexibility exercises incorporated during warm-up and cool-down phases. Training sessions were supervised by qualified instructors in university or private facilities to ensure adherence to safety standards.

Control group (n = 15): Women without a history of structured exercise, whose activity levels were limited to daily living tasks and compulsory school-based physical education.

Exclusion criteria included chronic cardiovascular, metabolic, or endocrine disorders; smoking or alcohol use; recent use of medications or supplements known to influence oxidative stress; and irregular or intermittent exercise participation. Baseline health screening confirmed all participants were free from chronic illness and suitable for inclusion.

Venous blood samples were collected from the antecubital vein between 07:00 and 09:00 a.m. following an overnight fast of at least 10 hours. Participants refrained from strenuous physical activity, alcohol, and caffeine for 24 hours prior to sampling. Serum was separated by centrifugation and stored at -80 °C until analysis.

Ischemia-modified albumin (IMA): Determined using the albumin-cobalt binding assay (Bar-Or method). Absorbance was measured at 470 nm, expressed in absorbance units (ABSU).

Total sulfhydryl groups (-SH): Measured using the Ellman method, based on the reduction of DTNB and expressed as μmol/L.

All analyses were conducted in duplicate, with strict internal quality control procedures, including calibration curves and reagent blanks. A single trained biochemist blinded to group allocation performed all assays to minimize analytical bias.

Statistical analyses were performed using IBM SPSS Statistics 22.0. Normality was assessed using the Shapiro-Wilk test, and group comparisons were made using independent samples t-tests. Effect sizes (Cohen's d) with 95% confidence intervals were calculated to assess the magnitude of differences.

Keywords
Ischemia-Modified Albumin, Total Sulfhydryl Groups, Oxidative Stress Biomarkers, Redox Remodeling, Antioxidant Capacity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07181044
Study groupRoleWhat they receive
Exercising WomenHealthy women aged 18-25 years who performed structured exercise training ≥3 sessions per week for at least 12 months. Training programs included aerobic, resistance, and flexibility exercise, each session lasting 60-90 minutes.
Sedentary ControlsHealthy women aged 18-25 years without a history of structured exercise. Physical activity limited to daily living and compulsory school-based physical education classes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum Ischemia-Modified Albumin (IMA)

    Change in serum ischemia-modified albumin (IMA) concentration, measured in absorbance units (ABSU) using the albumin-cobalt binding assay.

    Measured: Baseline (single fasting blood draw)

Secondary outcomes (1)
  1. Serum Total Sulfhydryl Groups (-SH)

    Change in serum total sulfhydryl (-SH) concentration, measured in μmol/L using the Ellman method.

    Measured: Baseline (single fasting blood draw)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2025
  2. Study start20 Jan 2022
  3. Primary completion20 Feb 2022
  4. Study completion20 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07181044
Sponsor's protocol ID
27750
Other IDs
27750
Acronym
IMA-SH & Exerc
Status last verified
Sep 2025
First submitted
4 Sep 2025
Last updated
23 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because the study involved a small sample of healthy young women and includes sensitive biomarker information. Data sharing is restricted by the ethics committee approval and participant consent, which did not authorize public distribution of individual-level data.

Publications

  • Bilici OF, Kahraman MZ, Turker A, Seyhan S, Sahin MF, Demir H, Acar G, Bilici MF, Soylu C, Sogut T, Bakum A. Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study. Front Physiol. 2025 Nov 20;16:1719454. doi: 10.3389/fphys.2025.1719454. eCollection 2025.

    PubMed 41357165

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Young Women and Regular Exercise, run by Duvenciler Anadolu Lİsesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum Ischemia-Modified Albumin (IMA) (time frame: Baseline (single fasting blood draw)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07181044, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in